These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hypoalphalipoproteinemia and BRAF Cohen-Aubart F; Guerin M; Poupel L; Cluzel P; Saint-Charles F; Charlotte F; Arsafi Y; Emile JF; Frisdal E; Le Goff C; Donadieu J; Amoura Z; Lesnik P; Haroche J; Le Goff W Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1913-1925. PubMed ID: 29930009 [TBL] [Abstract][Full Text] [Related]
7. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis. Hao X; Feng R; Bi Y; Liu Y; Li C; Lu T; Tian Y J Neurosurg Pediatr; 2019 Jan; 23(1):48-53. PubMed ID: 30265230 [TBL] [Abstract][Full Text] [Related]
8. Erdheim-Chester Disease: Comprehensive Review of Molecular Profiling and Therapeutic Advances. Haroun F; Millado K; Tabbara I Anticancer Res; 2017 Jun; 37(6):2777-2783. PubMed ID: 28551613 [TBL] [Abstract][Full Text] [Related]
9. Case report of a patient with Erdheim-Chester disease presenting with neuro-endocrine symptoms and negative for BRAF mutation. Lu L; Zhou J; Yan X; Jin R; Deng S; Lu W; Chen D Medicine (Baltimore); 2023 May; 102(20):e33846. PubMed ID: 37335698 [TBL] [Abstract][Full Text] [Related]
10. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm. Haroche J; Cohen-Aubart F; Charlotte F; Maksud P; Grenier PA; Cluzel P; Mathian A; Emile JF; Amoura Z Expert Rev Clin Immunol; 2015; 11(9):1033-42. PubMed ID: 26197238 [TBL] [Abstract][Full Text] [Related]
11. [Use of targeting therapy in Erdheim-Chester disease: A case report with neurologic involvement]. Berthe P; Rouzic N; Daelman L; Jacobzone C; Espitia A; Cohen-Aubart F; Haroche J; Émile JF; Lorleac'h A Rev Med Interne; 2020 Jun; 41(6):413-417. PubMed ID: 32113636 [TBL] [Abstract][Full Text] [Related]
12. Advances in Understanding and Management of Erdheim-Chester Disease. Kulkarni AM; Gayam PKR; Aranjani JM Life Sci; 2024 Jul; 348():122692. PubMed ID: 38710283 [TBL] [Abstract][Full Text] [Related]
13. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Picarsic J; Pysher T; Zhou H; Fluchel M; Pettit T; Whitehead M; Surrey LF; Harding B; Goldstein G; Fellig Y; Weintraub M; Mobley BC; Sharples PM; Sulis ML; Diamond EL; Jaffe R; Shekdar K; Santi M Acta Neuropathol Commun; 2019 Nov; 7(1):168. PubMed ID: 31685033 [TBL] [Abstract][Full Text] [Related]
14. Erdheim-Chester disease with bilateral orbital masses and multi-systemic symptoms: two case reports. Qiao J; Ma R; Peng X; He W World J Surg Oncol; 2023 Jul; 21(1):233. PubMed ID: 37525276 [TBL] [Abstract][Full Text] [Related]
16. Multisystem Erdheim-Chester disease presenting with pericardial effusion confirmed by the effusion cytology specimen. Dai S; Su X; Liu WP; Wu Y Cardiovasc Pathol; 2024; 70():107625. PubMed ID: 38417471 [TBL] [Abstract][Full Text] [Related]
17. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients. Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919 [TBL] [Abstract][Full Text] [Related]